We initially corroborated a substantial reduction in both the proportion and absolute count of ILC2s within the spleens of IL-33−/− tumor-bearing mice, in stark contrast to their wild-type tumor-bearing counterparts (Fig. 3B, C, E). The gene discussed is IL33; the disease is neoplasm.